Enriching and analyzing method of circulating tumor cells of colorectal cancer

A technology for tumor cells and colorectal cancer, applied in the field of medical detection and analysis, can solve the problems of inability to conduct in-depth analysis of CTC, high cost of instruments and consumables, and limitation of large-scale application, so as to improve the detection rate of CTC, low cost and low cost Effect

Inactive Publication Date: 2017-01-04
BEIJING KEXUN BIOTECH CO LTD
View PDF3 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, the CellSearch system itself also has unsolvable defects: 1. The detection sensitivity is not high enough
Some patients with metastatic cancer cannot be captured by the CellSearch system because the CTC content in their blo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enriching and analyzing method of circulating tumor cells of colorectal cancer
  • Enriching and analyzing method of circulating tumor cells of colorectal cancer
  • Enriching and analyzing method of circulating tumor cells of colorectal cancer

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0054] Example 1

[0055] A method for enrichment and analysis of circulating tumor cells in colorectal cancer, including the following steps:

[0056] A. Collection of peripheral blood mononuclear cells

[0057] 1. Use EDTA anticoagulation tube to collect about 10mL of patient blood sample.

[0058] 2. Using a pipette, measure 8 mL of blood sample into a BD Vacutainer CPT tube with the same mark.

[0059] 3. Centrifuge at 1700g room temperature for 25 minutes.

[0060] 4. After centrifugation, the white layer under the plasma layer is monocytes and platelets. Carefully aspirate about half of the plasma, and transfer the remaining plasma and cell layer (about 2 mL) to a sterile 15 mL centrifuge tube.

[0061] 5. Add RPMI 1640 medium to the above centrifuge tube to make the total volume 10 mL. Tighten the cap of the centrifuge tube and invert the centrifuge tube 5 times to mix the cells.

[0062] 6. Centrifuge at 300g for 15 minutes and remove the supernatant.

[0063] 7. Add 1mL PBS to the...

Example Embodiment

[0129] Example 2

[0130] A method for enrichment and analysis of circulating tumor cells in colorectal cancer, including the following steps:

[0131] A. Collection of peripheral blood mononuclear cells

[0132] 1. Use EDTA anticoagulation tube to collect about 10mL of patient blood sample.

[0133] 2. Using a pipette, measure 8 mL of blood sample into a BD Vacutainer CPT tube with the same mark.

[0134] 3. Centrifuge at 1700g room temperature for 25 minutes.

[0135] 4. After centrifugation, the white layer under the plasma layer is monocytes and platelets. Carefully aspirate about half of the plasma, and transfer the remaining plasma and cell layer (about 3 mL) to a sterile 15 mL centrifuge tube.

[0136] 5. Add RPMI 1640 medium to the above centrifuge tube to make the total volume 10 mL. Tighten the cap of the centrifuge tube and invert the centrifuge tube 5 times to mix the cells.

[0137] 6. Centrifuge at 300g for 15 minutes and remove the supernatant.

[0138] 7. Add 1mL PBS to the...

Example Embodiment

[0204] Example 3

[0205] A method for enrichment and analysis of circulating tumor cells in colorectal cancer, including the following steps:

[0206] A. Collection of peripheral blood mononuclear cells

[0207] 1. Use EDTA anticoagulation tube to collect about 10mL of patient blood sample.

[0208] 2. Using a pipette, measure 8 mL of blood sample into the BD Vacutainer CPT tube with the same mark.

[0209] 3. Centrifuge at 1700g room temperature for 25 minutes.

[0210] 4. After centrifugation, the white layer under the plasma layer is monocytes and platelets. Carefully aspirate about half of the plasma, and transfer the remaining plasma and cell layer (about 2 mL) to a sterile 15 mL centrifuge tube.

[0211] 5. Add RPMI 1640 medium to the above centrifuge tube to make the total volume 10 mL. Tighten the cap of the centrifuge tube and invert the centrifuge tube 5 times to mix the cells.

[0212] 6. Centrifuge at 300g for 15 minutes and remove the supernatant.

[0213] 7. Add 1mL PBS to t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an enriching and analyzing method of circulating tumor cells of colorectal cancer. The enriching and analyzing method is characterized by comprising: acquiring a human body blood sample and separating single nuclear cells in the human body blood sample; carrying out two times of enriching on the single nuclear cells by adopting two types of manners of backward enriching the single nuclear cells through CD45 magnetic beads and forward enriching the single nuclear cells through EpCAM magnetic beads, so as to obtain cell suspension; after cracking the cells, extracting mRNA (messenger Ribonucleic Acid); detecting expression levels of CK20 and Survivin genes of the circulating tumor cells of the colorectal cancer through an RT-qPCR detection method; after comparing the expression levels of the two genes with an existing expression level database of the CK20 and Survivin genes of normal people and colorectal cancer patients, analyzing to know whether the circulating tumor cells of the colorectal cancer exist or not and an expression degree. The enriching and analyzing method is a method for detecting the circulating tumor cells in blood of the colorectal cancer patients and has the advantages of high sensitivity and specificity and low cost.

Description

technical field [0001] The invention belongs to the technical field of medical detection and analysis, and in particular relates to a method for enrichment and analysis of colorectal cancer circulating tumor cells. Background technique [0002] Malignant tumor metastasis is an important cause of death in cancer patients. More and more molecular biology and clinical research results show that tumor metastasis may appear in the early stage of tumorigenesis. At present, the discovery and diagnosis of tumors still rely on imaging examinations and the monitoring of traditional tumor markers clinically. It is difficult to detect tumor metastasis or recurrence early, and it is also difficult to reflect the curative effect in a timely manner. [0003] Circulating tumor cells (CTCs) are tumor cells that have shed into the blood circulation. A large number of experiments have confirmed that the detection of CTCs is helpful for monitoring tumor recurrence and metastasis, judging the pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/09C12Q1/68
CPCC12N5/0693C12Q1/686C12Q1/6886C12Q2521/107C12Q2531/113
Inventor 周晔钟夏刘倩唐宇徐寒黎李伟伟李富威
Owner BEIJING KEXUN BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap